Mesh Medical Device News Desk, January 10, 2018 ~ She has been a very active member of the Canadian group of anti-mesh campaigners since 2011, now Noni Wideman is bringing demands directly to the Canadian government.
Image: Noni Wideman on CTV, Jan 2018
On Monday, January 8, CTV reporter Avis Favaro writes on the CTV National News blog about Noni Wideman.
As anti-mesh campaigners have done in Scotland and in England, Wideman has filed a petition to the House of Commons in Ottawa to stop the use of polypropylene plastic mesh implants until more study has been done to assure safety.
From Rose Prarie, British Columbia, Wideman has always been outspoken, contributing to a Patient Profile on Mesh News Desk in May 2012. Read it here.
Wideman was implanted with a TVT-Secur (Johnson & Johnson) mesh in 2011 to treat incontinence but soon she developed complications including fatigue and pain.
Polypropylene mesh taken from urine, Wideman
Blue plastic mesh particles were in her urine and poking out of her vagina. The more she researched, she learned she was not alone.
There were thousands of women in Canada and the U.S. also claiming adverse reactions to the polypropylene mesh.
Wideman’s research led to Links on Mesh, a chronicle of the lack of biocompatibility of polypropylene (PP) plastic mesh used to make medical devices of "mesh" used to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP).
Chrissy outpouring on FAcebook
The recent death of the mesh-injured Ontario woman, Chrissy Brajcic, encouraged Wideman to do more.
The e-Petition has more than 350 signatures (here) but will need up to 500 to be filed with the House of Commons. The Petition is open for signatures until April 20, 2018.
Wideman tells MND she is hoping to get a response from Health Canada and Parliamentary support.
“Our new government seems ready to address issues the past one ignored and swept under the table.”
In Canada, about 25,000 women have had surgery to treat stress urinary incontinence (SUI) where weakened pelvic muscles allow for the release of urine. CTV reports another 5,000 procedures are done for pelvic organ prolapse (POP) where the organs in the pelvic region literally fall sometimes outside of the body.
Canada followed the U.S. in allowing the mesh products, also called “tape” onto the market with little oversight and no clinical trials.
CALLS FOR SAFETY ASSURANCES
A recent British Medical Journal study (here) finds the regulatory bodies allowed untested implantable medical devices on the market with no assurances of safety and efficacy.
Wideman wants the government to oversee research where women with mesh implants are followed for at least five years. Typically testing cited by the manufacturers lasts one year or less. She wants to see the implant use suspended until those studies are done.
Wideman also calls for a registry of all implanted medical devices to watch for emerging complications. Canada does not currently have any way to track trends in complications. The U.S.’s MAUDE database within the Food and Drug Administration is not an active registry and captures a small percentage of events.
The medical establishment in Canada and the U.S. refuses to stop the use of mesh products because some surgeons say they are still useful in some patients.